SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001085146-24-005686
Filing Date
2024-11-13
Accepted
2024-11-14 08:37:20
Documents
1

Document Format Files

Seq Description Document Type Size
1 COWEN AND COMPANY, LLC urgna1_111224.htm SC 13G/A 35508
  Complete submission text file 0001085146-24-005686.txt   37358
Mailing Address 599 LEXINGTON AVENUE 20TH FLOOR NEW YORK NY 10022
Business Address 599 LEXINGTON AVENUE 20TH FLOOR NEW YORK NY 10022 212-827-6971
COWEN AND COMPANY, LLC (Filed by) CIK: 0000048966 (see all company filings)

IRS No.: 841702964 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007
Business Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007 972 9 770 7601
UroGen Pharma Ltd. (Subject) CIK: 0001668243 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-89992 | Film No.: 241457417
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)